^
    1year
    CHAARTED2: Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel (clinicaltrials.gov)
    P2, N=223, Active, not recruiting, ECOG-ACRIN Cancer Research Group | Trial primary completion date: Dec 2024 --> Mar 2025
    Trial primary completion date
    |
    AR (Androgen receptor)
    |
    AR splice variant 7 • AR-V7 positive • AR-V7 negative • AR splice variant 7 negative
    |
    docetaxel • abiraterone acetate • prednisone • cabazitaxel